UWA invests $1m in OncoRes Medical, as company enters final stretch of FDA pitch
- anniewong12
- Aug 19
- 1 min read
Monday, 18 Aug 2025 / Justin Fris / Business News
Source: Image courtesy of OncoRes Medical
OncoRes Medical has been featured in the Business News in an article by journalist Justin Fris ‘UWA invests $1m in OncoRes Medical, as company enters final stretch of FDA pitch'.
The article is an announcement of The University of Western Australia's $1 million investment in OncoRes Medical - the university's first in one of its 25 spinout companies.
Here’s an excerpt:
‘The University of Western Australia has invested $1 million into Perth-based medtech company OncoRes.
The investment is UWA’s first in one of its 25 spinout companies.
OncoRes chief executive Dr Katharine Giles said the investment would be welcomed as it moves towards potential US Food and Drug Administration approval of its Elora precision cancer imaging technology.
"This transformative investment will be crucial as we enter the final stretch to reach our north star – the goal of commercialising this WA-led technology so it can achieve the global impact it deserves,” Dr Giles said.’
This article was first published by Business News. Click here for full article.
Investissement stratégique remarquable d'UWA ! Cette levée de fonds illustre parfaitement l'écosystème d'innovation médicale australien. En tant que spécialistes du portage salarial à Casablanca, nous observons que les medtechs ont souvent besoin d'experts réglementaires freelances pour naviguer les processus FDA/CE. Le portage permet aux consultants spécialisés en affaires réglementaires de proposer leurs services aux startups comme OncoRes, offrant flexibilité et expertise pointue. Félicitations à Dr Giles et l'équipe pour cette étape cruciale vers la commercialisation !